Archive-2017
Clinical Pharmacology and Translational Medicine (CPTM)
Volume 1
Volume 1, Issue 1
Inagural Editorial: Clinical Pharmacology and Translational Medicine (CPTM)
Inagural Editorial from Editor-in-Chief
Segura-Aguilar J
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Impact of Interaction of Ca2+/Camp Intracellular Signalling Pathways in Clinical Pharmacology and Translational Medicine
Leandro Bueno Bergantin and Afonso Caricati-Neto
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Why We Cannot Translate Successful Results to New Therapies in Parkinson’s Disease.
Patricia Muñoz and Juan Segura-Aguilar
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Nicotinic Receptor Intervention in Parkinson’s Disease: Future Directions
Yousef Tizabi and Bruk Getachew
Volume 1, Issue 2
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
The Relevance of Intranasal Route in Parkinson’s Disease: from Physiopathological Alterations to Administration of Neurotoxins
Tuane Bazanella Sampaio, Katiane Roversi, Marissa Giovanna Schamne, Andréia Simões Cunha1, Angela Patricia França, Ana Elisa Speck, João Paulo Lima Daher, Roger Walz, Rui Daniel Prediger
Research Article: Clinical Pharmacology and Translational Medicine (CPTM)
Contributing factors to the use of erythropoiesis stimulating agents in patients with chronic kidney disease on peritoneal dialysis program: A Cross-Sectional Study.
Anxo Fernández-Ferreiro, Mara Lisbet Cabana-Carcasi, Rafael Alonso-Valente, Eduardo Echarri-Arrieta, Sara Blanco-Dorado, Antón Fernández-Ferreiro, Miguel González-Barcia, MJ Lamas
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Antioxidants in human disease: Potential therapeutic opportunities
Ramón Rodrigo, Roberto Brito, Jaime González-Montero, Vincenzo Benedetti
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Neuroprotective and Therapeutic Strategies for Manganese–Induced Neurotoxicity.
Marreilha dos Santos AP, Andrade V, Aschner M
Volume 1, Issue 3
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
The Roles of Autophagy in Parkinson’s disease.
Yakhine-Diop, R. Gómez-Sánchez, JM Bravo-San Pedro, RA González Polo, JM Fuentes
Commentary: Clinical Pharmacology and Translational Medicine (CPTM)
NRF2: A Potential Therapeutic Agent in Cancer.
Patricia Muñoz S and Paula Castillo
Volume 1, Issue 1
Inagural Editorial: Clinical Pharmacology and Translational Medicine (CPTM)
Inagural Editorial from Editor-in-Chief
Segura-Aguilar J
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Impact of Interaction of Ca2+/Camp Intracellular Signalling Pathways in Clinical Pharmacology and Translational Medicine
Leandro Bueno Bergantin and Afonso Caricati-Neto
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Why We Cannot Translate Successful Results to New Therapies in Parkinson’s Disease.
Patricia Muñoz and Juan Segura-Aguilar
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Nicotinic Receptor Intervention in Parkinson’s Disease: Future Directions
Yousef Tizabi and Bruk Getachew
Volume 1, Issue 2
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
The Relevance of Intranasal Route in Parkinson’s Disease: from Physiopathological Alterations to Administration of Neurotoxins
Tuane Bazanella Sampaio, Katiane Roversi, Marissa Giovanna Schamne, Andréia Simões Cunha1, Angela Patricia França, Ana Elisa Speck, João Paulo Lima Daher, Roger Walz, Rui Daniel Prediger
Research Article: Clinical Pharmacology and Translational Medicine (CPTM)
Contributing factors to the use of erythropoiesis stimulating agents in patients with chronic kidney disease on peritoneal dialysis program: A Cross-Sectional Study.
Anxo Fernández-Ferreiro, Mara Lisbet Cabana-Carcasi, Rafael Alonso-Valente, Eduardo Echarri-Arrieta, Sara Blanco-Dorado, Antón Fernández-Ferreiro, Miguel González-Barcia, MJ Lamas
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Antioxidants in human disease: Potential therapeutic opportunities
Ramón Rodrigo, Roberto Brito, Jaime González-Montero, Vincenzo Benedetti
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Neuroprotective and Therapeutic Strategies for Manganese–Induced Neurotoxicity.
Marreilha dos Santos AP, Andrade V, Aschner M
Volume 1, Issue 3
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
The Roles of Autophagy in Parkinson’s disease.
Yakhine-Diop, R. Gómez-Sánchez, JM Bravo-San Pedro, RA González Polo, JM Fuentes
Commentary: Clinical Pharmacology and Translational Medicine (CPTM)
NRF2: A Potential Therapeutic Agent in Cancer.
Patricia Muñoz S and Paula Castillo
Inagural Editorial from Editor-in-Chief
Segura-Aguilar J
Impact of Interaction of Ca2+/Camp Intracellular Signalling Pathways in Clinical Pharmacology and Translational Medicine
Leandro Bueno Bergantin and Afonso Caricati-Neto
Why We Cannot Translate Successful Results to New Therapies in Parkinson’s Disease.
Patricia Muñoz and Juan Segura-Aguilar
Nicotinic Receptor Intervention in Parkinson’s Disease: Future Directions
Yousef Tizabi and Bruk Getachew
Volume 1, Issue 2
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
The Relevance of Intranasal Route in Parkinson’s Disease: from Physiopathological Alterations to Administration of Neurotoxins
Tuane Bazanella Sampaio, Katiane Roversi, Marissa Giovanna Schamne, Andréia Simões Cunha1, Angela Patricia França, Ana Elisa Speck, João Paulo Lima Daher, Roger Walz, Rui Daniel Prediger
Research Article: Clinical Pharmacology and Translational Medicine (CPTM)
Contributing factors to the use of erythropoiesis stimulating agents in patients with chronic kidney disease on peritoneal dialysis program: A Cross-Sectional Study.
Anxo Fernández-Ferreiro, Mara Lisbet Cabana-Carcasi, Rafael Alonso-Valente, Eduardo Echarri-Arrieta, Sara Blanco-Dorado, Antón Fernández-Ferreiro, Miguel González-Barcia, MJ Lamas
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Antioxidants in human disease: Potential therapeutic opportunities
Ramón Rodrigo, Roberto Brito, Jaime González-Montero, Vincenzo Benedetti
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
Neuroprotective and Therapeutic Strategies for Manganese–Induced Neurotoxicity.
Marreilha dos Santos AP, Andrade V, Aschner M
The Relevance of Intranasal Route in Parkinson’s Disease: from Physiopathological Alterations to Administration of Neurotoxins
Tuane Bazanella Sampaio, Katiane Roversi, Marissa Giovanna Schamne, Andréia Simões Cunha1, Angela Patricia França, Ana Elisa Speck, João Paulo Lima Daher, Roger Walz, Rui Daniel Prediger
Contributing factors to the use of erythropoiesis stimulating agents in patients with chronic kidney disease on peritoneal dialysis program: A Cross-Sectional Study.
Anxo Fernández-Ferreiro, Mara Lisbet Cabana-Carcasi, Rafael Alonso-Valente, Eduardo Echarri-Arrieta, Sara Blanco-Dorado, Antón Fernández-Ferreiro, Miguel González-Barcia, MJ Lamas
Antioxidants in human disease: Potential therapeutic opportunities
Ramón Rodrigo, Roberto Brito, Jaime González-Montero, Vincenzo Benedetti
Neuroprotective and Therapeutic Strategies for Manganese–Induced Neurotoxicity.
Marreilha dos Santos AP, Andrade V, Aschner M
Volume 1, Issue 3
Review Article: Clinical Pharmacology and Translational Medicine (CPTM)
The Roles of Autophagy in Parkinson’s disease.
Yakhine-Diop, R. Gómez-Sánchez, JM Bravo-San Pedro, RA González Polo, JM Fuentes
Commentary: Clinical Pharmacology and Translational Medicine (CPTM)
NRF2: A Potential Therapeutic Agent in Cancer.
Patricia Muñoz S and Paula Castillo
The Roles of Autophagy in Parkinson’s disease.
Yakhine-Diop, R. Gómez-Sánchez, JM Bravo-San Pedro, RA González Polo, JM Fuentes
NRF2: A Potential Therapeutic Agent in Cancer.
Patricia Muñoz S and Paula Castillo